Published in J Neurosurg Spine on January 01, 2012
Reliability in the location of hindlimb motor representations in Fischer-344 rats: laboratory investigation. J Neurosurg Spine (2013) 0.85
Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. J Neurooncol (2012) 0.79
Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres. J Neurosurg (2014) 0.75
Output Properties of the Cortical Hindlimb Motor Area in Spinal Cord-Injured Rats. J Neurotrauma (2015) 0.75
A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48
Paclitaxel (taxol) N Engl J Med (1995) 5.79
Intramedullary spinal cord astrocytomas in children. Pediatr Blood Cancer (2004) 2.38
MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma (1996) 2.23
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg (2009) 1.91
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol (2004) 1.83
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg (2004) 1.78
Adjuvant chemotherapy in the treatment of high grade gliomas. Cancer Treat Rev (2005) 1.77
Targeted therapy for brain tumours. Nat Rev Drug Discov (2004) 1.63
Spinal tumors. Eur J Radiol (2004) 1.47
Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord (2005) 1.39
Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res (2005) 1.35
Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol (2008) 1.31
Mechanism of taxane neurotoxicity. Breast Cancer (2004) 1.26
Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys (1992) 1.23
Taxol: a review of its preclinical in vivo antitumor activity. Anticancer Drugs (1992) 1.21
Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. J Vet Intern Med (2004) 1.21
Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J Neurooncol (2004) 1.20
Convection enhanced delivery for the treatment of malignant gliomas: symposium review. J Neurooncol (2005) 1.16
Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer. Acta Oncol (2004) 1.14
Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis. J Neurosurg Spine (2005) 1.08
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst (1995) 1.08
Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res (1994) 1.04
Intramedullary spinal cord tumors in children. Childs Nerv Syst (2003) 1.03
Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw (2005) 1.01
Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Neurosurgery (2010) 1.00
Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 0.95
Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer. Oncology (2004) 0.91
A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats. J Neurosurg (2010) 0.91
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. J Neurooncol (2005) 0.90
Pharmacokinetics of high-dose chemotherapy. Bone Marrow Transplant (2004) 0.88
Local delivery of oncogel delays paresis in rat metastatic spinal tumor model. J Neurosurg Spine (2007) 0.87
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer. Br J Cancer (2004) 0.86
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol (2004) 0.86
Intrinsic spinal cord tumor resection. Neurosurgery (2001) 0.85
Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk. Hematol Oncol Clin North Am (2004) 0.85
Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol (1997) 0.85
Neuro-oncology: the growing role of chemotherapy in glioma. Lancet Neurol (2005) 0.85
Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res (2003) 0.83
Local anti-angiogenic brain tumor therapies. J Neurooncol (2001) 0.83
Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol (2006) 0.83
Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours. Expert Opin Biol Ther (2005) 0.82
Chemotherapy for intramedullary spinal cord tumors. J Neurooncol (2000) 0.82
A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Neurosurgery (2006) 0.81
Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation. Prostate (2004) 0.80
Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis. Neurosurgery (2009) 0.77
Microsurgical removal of intramedullary spinal cord gliomas in a rat spinal cord decreases onset to paresis, an animal model for intramedullary tumor treatment. Childs Nerv Syst (2008) 0.77
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Patterns of care for adults with newly diagnosed malignant glioma. JAMA (2005) 3.08
Achieving the National Quality Forum's "Never Events": prevention of wrong site, wrong procedure, and wrong patient operations. Ann Surg (2007) 3.04
Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg (2009) 2.70
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Seizure control for patients undergoing meningioma surgery. World Neurosurg (2012) 2.19
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Preoperative charlson comorbidity score predicts postoperative outcomes among older intracranial meningioma patients. World Neurosurg (2011) 2.09
[Human rabies encephalitis by a vampire bat bite in an urban area of Colombia]. Biomedica (2009) 2.08
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg (2009) 1.91
Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg (2009) 1.83
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
An integrated system for planning, navigation and robotic assistance for skull base surgery. Int J Med Robot (2008) 1.81
Arachnoid cysts: case series and review of the literature. Neurosurg Focus (2007) 1.78
Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery (2008) 1.72
Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg (2012) 1.72
EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc (2006) 1.69
Disparities in access to neuro-oncologic care in the United States. Arch Surg (2010) 1.67
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2005) 1.63
Targeted therapy for brain tumours. Nat Rev Drug Discov (2004) 1.63
Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. J Neurosurg (2002) 1.54
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol (2013) 1.51
Lysis of intracerebral hematoma with stereotactically implanted tissue plasminogen activator polymers in a rabbit model. J Neurosurg (2006) 1.47
Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery (2004) 1.47
Postoperative mortality after surgery for brain tumors by patient insurance status in the United States. Arch Surg (2012) 1.47
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg (2003) 1.47
Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf (2007) 1.46
Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. J Neurosurg (2011) 1.42
Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs (2004) 1.40
Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery (2003) 1.39
Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol (2008) 1.31
Advancing the field of drug delivery: taking aim at cancer. Cancer Cell (2003) 1.28
Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol (2010) 1.24
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther (2009) 1.18
Exomic sequencing of four rare central nervous system tumor types. Oncotarget (2013) 1.17
Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. J Neurosurg (2004) 1.16
Solitary thoracic osteochondroma: case report and review of the literature. Neurosurgery (2005) 1.15
Central nervous system cancers. J Natl Compr Canc Netw (2011) 1.13
Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol (2006) 1.12
Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery (2006) 1.11
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res (2005) 1.11
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin Cancer Res (2006) 1.10
Disparities in access to pediatric neurooncological surgery in the United States. Pediatrics (2009) 1.09
Diagnosis and management of vein of galen aneurysmal malformations. J Perinatol (2005) 1.08
A novel rat model for the study of intraosseous metastatic spine cancer. J Neurosurg Spine (2005) 1.08
Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res (2007) 1.07
Aneurysmal rupture without subarachnoid hemorrhage: case series and literature review. Neurosurgery (2005) 1.07
Local drug delivery to the brain. Adv Drug Deliv Rev (2002) 1.07
Latex injection of cadaver heads: technical note. Neurosurgery (2010) 1.06
Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother Pharmacol (2007) 1.05
Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg (2010) 1.02
The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.01
In vivo release from a drug delivery MEMS device. J Control Release (2004) 1.01
Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw (2005) 1.01
Perioperative and long-term outcomes from the management of parasagittal meningiomas invading the superior sagittal sinus. Neurosurgery (2010) 1.00
Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Neurosurgery (2010) 1.00
Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg (2004) 0.99
Harvey Cushing's attempt at the first human pituitary transplantation. Nat Rev Endocrinol (2010) 0.98
Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest (2004) 0.98
Craniotomy vs. craniectomy for posterior fossa tumors: a prospective study to evaluate complications after surgery. Acta Neurochir (Wien) (2013) 0.98
Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials (2011) 0.98
The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging. AJR Am J Roentgenol (2003) 0.96
Endothelial function in patients with migraine during the interictal period. Headache (2007) 0.96
Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano (2015) 0.96
Short-term progressive spinal deformity following laminoplasty versus laminectomy for resection of intradural spinal tumors: analysis of 238 patients. Neurosurgery (2010) 0.95
The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival. Neurol Res (2011) 0.93
Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival. Childs Nerv Syst (2012) 0.92
Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus. Childs Nerv Syst (2006) 0.91
Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas. Neurol Res (2009) 0.91
Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy. J Neurooncol (2002) 0.91
A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats. J Neurosurg (2010) 0.91
The value of intraoperative motor evoked potential monitoring during surgical intervention for thoracic idiopathic spinal cord herniation. J Neurosurg Spine (2011) 0.91
OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev (2009) 0.91
Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J Control Release (2007) 0.90
Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults. J Neurosurg (2010) 0.90
Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors. Ann Surg Oncol (2010) 0.89
Surgical navigation with a head-mounted tracking system and display. Stud Health Technol Inform (2013) 0.89
Harvey Cushing's use of a transplanted human vein to treat hydrocephalus in an infant in the early 1900s. Historical vignette. J Neurosurg Pediatr (2010) 0.89
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res (2012) 0.88
Complications and death among elderly patients undergoing pituitary tumour surgery. Clin Endocrinol (Oxf) (2010) 0.88
A novel intravertebral tumor model in rabbits. Neurosurgery (2005) 0.88
In vivo delivery of BCNU from a MEMS device to a tumor model. J Control Release (2005) 0.88
Pericytic-like angiotropism of glioma and melanoma cells. Am J Dermatopathol (2002) 0.88
Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol (2008) 0.88
Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma. J Neurooncol (2003) 0.87
Regression of intracranial meningioma following intratumoral hemorrhage. J Clin Neurosci (2009) 0.87